Glomerular disease in 2014: Advances in basic science and translational medicine

Research output: Contribution to journalArticle

3 Scopus citations


Knowledge of the pathogenesis of glomerular disease and approaches to therapy continued to advance in 2014. Key studies identified thrombospondin type-1 domain-containing protein 7A as an antigenic target in primary membranous nephropathy, and demonstrated efficacy of rituximab as maintenance therapy in relapsing or steroid-dependent nephrotic syndrome and antineutrophil cytoplasmic antibody-associated vasculitis.

Original languageEnglish (US)
Pages (from-to)46-47
Number of pages2
JournalNature Reviews Gastroenterology and Hepatology
Issue number1
StatePublished - Jan 1 2015


ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this